Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
Sarcopenia prior to nerve-sparing robot-assisted radical prostatectomy is significantly associated with sexual dysfunction after the surgery, according to investigators.
A recent Morbidity and Mortality Weekly Report (MMWR) highlights the risks associated with use of over-the-counter (OTC) products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
By watching what they eat and drink, patients can control such common problems as overactive bladder, prostatitis, interstitial cystitis, and chronic kidney disease.
Erectile function improved significantly among men with ED in the placebo arms of clinical trials of phosphodiesterase 5 inhibitors, especially among those with posttraumatic stress disorder, a meta-analysis revealed.
Investigators found a significant positive correlation between transitional zone index (TZI) and IPSS and a significant negative correlation between TZI and both the International Index of Erectile Function and penile peak systolic velocity.
In a study, localized prostate cancer patients reported clinically meaningful differences in urinary, bowel, sexual, and hormonal function by management option up to 5 years of follow-up.
